You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

AUGMENTIN ES-600 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Augmentin Es-600 patents expire, and what generic alternatives are available?

Augmentin Es-600 is a drug marketed by Us Antibiotics and is included in one NDA.

The generic ingredient in AUGMENTIN ES-600 is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AUGMENTIN ES-600?
  • What are the global sales for AUGMENTIN ES-600?
  • What is Average Wholesale Price for AUGMENTIN ES-600?
Summary for AUGMENTIN ES-600
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 15
Clinical Trials: 75
Patent Applications: 705
What excipients (inactive ingredients) are in AUGMENTIN ES-600?AUGMENTIN ES-600 excipients list
DailyMed Link:AUGMENTIN ES-600 at DailyMed
Drug patent expirations by year for AUGMENTIN ES-600
Recent Clinical Trials for AUGMENTIN ES-600

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Daniel MerensteinPhase 4
University of California, Los AngelesPhase 4
Medstar Health Research InstitutePhase 4

See all AUGMENTIN ES-600 clinical trials

Pharmacology for AUGMENTIN ES-600

US Patents and Regulatory Information for AUGMENTIN ES-600

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Antibiotics AUGMENTIN ES-600 amoxicillin; clavulanate potassium FOR SUSPENSION;ORAL 050755-001 Jun 22, 2001 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.